Institutional investors purchased a net $2.1 million shares of AGN during the quarter ended December 2015 and now own 90.44% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Generic industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
J.O. HAMBRO CAPITAL MANAGEMENT L... Bought 283.3 Thousand shares of Allergan
GWL INVESTMENT MANAGEMENT Bought 216.6 Thousand shares of Allergan
BNP PARIBAS ARBITRAGE SNC Bought 106.6 Thousand shares of Allergan